Novavax reported 303K in Interest Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adma Biologics ADMA:US 2.27K 30.8K
BioCryst Pharmaceuticals BCRX:US 609K 555K
Dynavax Technologies DVAX:US 765K 504K
Geron GERN:US 330K 218K
MannKind MNKD:US 516K 139K
Moderna Inc MRNA:US 40M 25M
Pain Therapeutics PTIE:US 314K 283K
Pfizer PFE:US 30M 16M
Sarepta Therapeutics SRPT:US 2.41M 2.24M